Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded promising insights into new therapeutic approaches. Current research centers on targeting the underlying causes of MSA. One strategy under investigation involves therapeutic interventions to modulate the activity of specific brain